Probucol inhibits the initiation of atherosclerosis in cholesterol-fed rabbits - Wikidata - awgldk - TriplyDB

Probucol inhibits the initiation of atherosclerosis in cholesterol-fed rabbits

Probucol inhibits the initiation of atherosclerosis in cholesterol-fed rabbits

http://www.wikidata.org/entity/Q41984713

about

Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine Add-on effect of probucol in atherosclerotic, cholesterol-fed rabbits treated with atorvastatin The Heart Protection Effect of Alcalase Potato Protein Hydrolysate Is through IGF1R-PI3K-Akt Compensatory Reactivation in Aging Rats on High Fat Diets.An Atherogenic Paigen-Diet Aggravates Nephropathy in Type 2 Diabetic OLETF Rats The hematologic effects of low intensity 650 nm laser irradiation on hypercholesterolemia rabbits.Terminalia paniculata bark extract attenuates non-alcoholic fatty liver via down regulation of fatty acid synthase in high fat diet-fed obese rats Pharmacological modulation of dietary lipid-induced cerebral capillary dysfunction: Considerations for reducing risk for Alzheimer's disease.Probucol attenuates overt pain-like behavior and carrageenan-induced inflammatory hyperalgesia and leukocyte recruitment by inhibiting NF-кB activation and cytokine production without antioxidant effects.Time course-changes in phosphatidylcholine profile during oxidative modification of low-density lipoprotein.Atorvastatin combined with poly-unsaturated fatty acid confers better improvement of dyslipidemia and endothelium function Effects of rosuvastatin combined with fasudil therapy on rabbits with dyslipidemia.Protective effect of co-administration of rosuvastatin and probucol on atherosclerosis in rats.Combination of rosuvastatin and probucol inhibits MMP-9 expression via upregulation of miR-497 in cultured HUVECs and apoE knockout mice.A cynomolgus monkey model of carotid atherosclerosis induced by puncturing and scratching of the carotid artery combined with a high-fat diet.

P2860

Q26853133-BD82CE32-F482-4639-B8DB-303F6AA27676 Q28538633-840AC5E7-C78D-4708-B7BD-7BD9B397AA9C Q35723223-AEA28B07-B967-4E9C-8BA2-C0AFF7F38A93 Q35852316-FD59BFDD-CBE4-4AD0-BF32-20D062BD362C Q36062107-736071FC-8C9E-41AB-BD50-C56756F6A6A1 Q37735071-2F3C6603-18C6-4915-8B4C-C881EC4515E3 Q38672178-416AE69C-C1EA-488C-B22B-5A2D66741D3E Q38848760-1FBE5137-3CFA-4352-B60E-73B11B803704 Q39153624-4D4A595A-07A6-4158-8E2B-96FA14772B3B Q42128953-CA4557AD-A8E0-4960-9D54-213BA54B9359 Q42517676-A4F48B86-665D-458F-A411-687A35CDE44D Q53021675-1FEF9DD2-BA43-441C-B2CD-A3BB7F96CF21 Q53305102-6B85E42D-F483-4DA8-887B-54DECF114969 Q55420273-3C0BD2C1-AB86-47E1-B817-F0FB2E4C0480

P2860

Probucol inhibits the initiation of atherosclerosis in cholesterol-fed rabbits

http://www.wikidata.org/entity/Q41984713

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Probucol inhibits the initiation of atherosclerosis in cholesterol-fed rabbits

@en

type

label

Probucol inhibits the initiation of atherosclerosis in cholesterol-fed rabbits

@en

prefLabel

Probucol inhibits the initiation of atherosclerosis in cholesterol-fed rabbits

@en

P1433

Q41984713-F9247C7C-E74D-4B49-8576-0C3F89C2510D

P1476

Q41984713-3D0386DF-15AD-42D0-A6B1-90872102ABFC

P2093

Q41984713-0D8E7A88-FD2A-41FC-99E5-2AC642609582

Q41984713-16CE9456-6333-4ABE-B080-776D9BE2B8DC

Q41984713-2055C978-5228-4168-9FF8-09D1064A497E

Q41984713-757092FF-C346-44E4-9CE5-57C9D1BC389D

Q41984713-9E196D87-5BC3-4E8C-AF30-7A5EEBFB34E9

Q41984713-B015C534-5C1D-4F5F-9505-321BD1783F7B

Q41984713-D6B33B59-FDC2-49E5-88EC-58698619C0DC

Q41984713-E5B052AC-286C-4ED6-9EB7-BDA8B784018B

P2860

Q41984713-08877E33-DD5D-48E4-8D9D-DE23F71D752A

Q41984713-20E58C41-A473-4C19-951F-967EADD032FF

Q41984713-3357F04B-A061-43A1-A7A8-211DF1548878

Q41984713-4D9A4524-6D83-4F85-9BC8-F72A74DEE355

Q41984713-6120D415-2E50-4B70-85AF-BBFA3F534A81

Q41984713-7BE0957F-163E-4B3B-ACB7-C82CB4840B04

Q41984713-7C4D381A-4D6B-4083-8661-D82781A681F7

Q41984713-872A94EB-510C-4002-9239-FAFC31E87148

Q41984713-9BDB05B6-FF84-494D-9240-3723575F06DB

Q41984713-A18835EE-E58B-475D-B693-A4674C1718D0

P2888

Q41984713-DF8ECF3E-10D8-40A7-A4E8-24CC1F7814A8

P304

Q41984713-FD1D49CB-1B60-49C8-BBBF-DC8B9B19A04C

P31

Q41984713-3F6D45B0-B36A-4C9A-A4DE-04E2A456716B

P356

Q41984713-1F22E388-CC94-457A-9C33-AB3628D9659D

P478

Q41984713-2FE7C40B-6CB1-486B-B85B-56FEBF85CAD9

P577

Q41984713-056E7BFA-844D-4536-B1FF-C4C402B331D5

P6179

Q41984713-A9232026-5234-4368-8ECD-88CCD040BDEF

P698

Q41984713-ACFFBAF7-C646-4D80-AFDF-E5BBCC682C46

P921

Q41984713-8B581C47-AC0B-4D59-9512-C059C664471E

P932

Q41984713-54C4F93A-2D7E-49E4-8465-C42B930F169A

P356

1476-511X-12-166

P1433

Lipids in Health and Disease

P1476

Probucol inhibits the initiation of atherosclerosis in cholesterol-fed rabbits

@en

P2093

Jianglin Fan

http://www.w3.org/2001/XMLSchema#string

Manabu Niimi

http://www.w3.org/2001/XMLSchema#string

Masanori Nozako

http://www.w3.org/2001/XMLSchema#string

Masayuki Kohashi

http://www.w3.org/2001/XMLSchema#string

Reiko Yasufuku

http://www.w3.org/2001/XMLSchema#string

Takashi Koyama

http://www.w3.org/2001/XMLSchema#string

Tomohiro Yoshikawa

http://www.w3.org/2001/XMLSchema#string

Yuka Keyamura

http://www.w3.org/2001/XMLSchema#string

P2860

Probucol attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits

Cilostazol inhibits accumulation of triglyceride in aorta and platelet aggregation in cholesterol-fed rabbits

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Macrophages in the pathogenesis of atherosclerosis

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

Progress and challenges in translating the biology of atherosclerosis

Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors.

Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia

Pharmacologic suppression of hepatic ATP-binding cassette transporter 1 activity in mice reduces high-density lipoprotein cholesterol levels but promotes reverse cholesterol transport.

Human apolipoprotein A-II protects against diet-induced atherosclerosis in transgenic rabbits.

P2888

1476-511x-12-166

P304

166

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1476-511X-12-166

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1006015983

http://www.w3.org/2001/XMLSchema#string

P698

24188322

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

4228370

http://www.w3.org/2001/XMLSchema#string